The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization

Virology

Volumn 312, Issue 2, 2003, Pages 320-329

  Moorman, Jonathan P ^a   Prayther, Deborah ^a   McVay, Derek ^a   Hahn, Young S ^b   Hahn, Chang S ^b  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Caspase; Core protein; Fas; Hepatitis C; Immune evasion; Lymphocyte; Sindbis virus; Viral persistence

Indexed keywords

CASPASE 3; CASPASE 8; CORE PROTEIN; FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; HEPATITIS C VIRUS; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; LEUKEMIA CELL LINE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RECEPTOR BINDING; VIRUS INFECTION;

HEPATITIS C VIRUS; SINDBIS VIRUS;

EID: 0043064047     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00208-3     Document Type: Article

References (42)

1. Adamson P., Marshall C.J., Hall A., Tilbrook P.A. Post-translational modifications of p21rho proteins. J. Biol. Chem. 267:1992;20033-20038.
2. Alter M.J. Epidemiology of hepatitis C. Eur. J. Gastroenterol. Hepatol. 8:1996;319-323.
3. Ashkenazi A., Dixit V.M. Death receptors signaling and modulation . Science. 281:1998;1305-1308.
4. Barba G., Harper F., Harada T., Kohara M., Goulinet S., Matsuura Y., Eder G., Schaff Z., Chapman M.J., Miyamura T., Brechot C. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. USA. 94:1997;1200-1205.
5. Boisvert J., He X.S., Cheung R., Keeffe E.B., Wright T., Greenberg H.B. Quantitative analysis of hepatitis C virus in peripheral blood and liver replication detected only in liver . J. Infect. Dis. 184:2001;827-835.
6. Bronowicki J.P., Loriot M.A., Thiers V., Grignon Y., Zignego A.L., Brechot C. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice [see comments]. Hepatology. 28:1998;211-218.
7. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P.J., et al. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:(6):1991;2451-2455.
8. Cribier B., Schmitt C., Bingen A., Kirn A., Keller F. In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. J. Gen. Virol. 76:1995;2485-2491.
9. Farci P., Bukh J., Purcell R.H. The quasispecies of hepatitis C virus and the host immune response. Springer Semin. Immunopathol. 19:1997;5-26.
10. Giannini C., Caini P., Giannelli F., Fontana F., Kremsdorf D., Brechot C., Zignego A.L. Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways. J. Gen. Virol. 83:(Pt. 7):2002;1665-1671.
11. Hahn C., Cho Y., Kang B., Lester I., Hahn Y. The HCV core protein acts a positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology. 276:2000;127-137.
12. Honda M., Kaneko S., Sakai A., Unoura M., Murakami S., Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology. 20:1994;1144-1151.
13. Kanazawa Y., Hayashi N., Mita E., Li T., Hagiwara H., Kasahara A., Fusamoto H., Kamada T. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology. 20:1994;1121-1130.
14. Krammer P.H. CD95's deadly mission in the immune system. Nature. 407:2000;789-795.
15. Large M.K., Kittlesen D.J., Hahn Y.S. Suppression of host immune response by the core protein of hepatitis C virus possible implications for hepatitis C virus persistence . J. Immunol. 162:1999;931-938.
16. Lechmann M., Ihlenfeldt H., Braunschweiger I., Giers G., Jung G., Matz B., Kaiser R., Sauerbruch T., Spengler U. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology. 24:1996;790-795.
17. Liu Z.X., Nishida H., He J.W., Lai M.M., Feng N., Dennert G. Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity. J. Virol. 76:2002;990-997.
18. Lo S.Y., Masiarz F., Hwang S.B., Lai M.M., Ou J.H. Differential subcellular localization of hepatitis C virus core gene products. Virology. 213:1995;455-461.
19. Martin D.A., Siegel R.M., Zheng L., Lenardo M.J. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. J. Biol. Chem. 273:1998;4345-4349.
20. Matsumoto M., Hsieh T.Y., Zhu N., VanArsdale T., Hwang S.B., Jeng K.S., Gorbalenya A.E., Lo S.Y., Ou J.H., Ware C.F., Lai M.M. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J. Virol. 71:1997;1301-1309.
21. Matsumoto M., Hwang S.B., Jeng K.S., Zhu N., Lai M.M. Homotypic interaction and multimerization of hepatitis C virus core protein. Virology. 218:1996;43-51.
22. Moorman J., Joo M., Hahn Y. Evasion of host immune surveillance by hepatitis C virus potential roles in viral persistence . Arch. Immunol. Ther. Exp. (Warsz.). 49:2001;189-194.
23. Moorman J.P., Bobak D.A., Hahn C.S. Inactivation of the small GTP binding protein Rho induces multinucleate cell formation and apoptosis in murine T lymphoma EL4. J. Immunol. 156:1996;4146-4153.
24. Moorman J.P., Luu D., Wickham J., Bobak D.A., Hahn C.S. A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival. Oncogene. 18:1999;47-57.
25. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449-1456.
26. Nelson D.R., Marousis C.G., Davis G.L., Rice C.M., Wong J., Houghton M., Lau J.Y. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 158:1997;1473-1481.
27. Ray R.B., Steele R., Basu A., Meyer K., Majumder M., Ghosh A.K., Ray R. Distinct functional role of Hepatitis C virus core protein on NF-kappaB regulation is linked to genomic variation. Virus Res. 87:2002;21-29.
28. Rehemtulla A., Hamilton C.A., Chinnaiyan A.M., Dixit V.M. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J. Biol. Chem. 272:1997;25783-25786.
29. Rehermann B., Chang K.M., McHutchinson J., Kokka R., Houghton M., Rice C.M., Chisari F.V. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. 70:1996;7092-7102.
30. Rehermann B., Chang K.M., McHutchison J.G., Kokka R., Houghton M., Chisari F.V. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1996;1432-1440.
31. Ruggieri A., Harada T., Matsuura Y., Miyamura T. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology. 229:1997;68-76.
32. Santolini E., Migliaccio G., La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68:1994;3631-3641.
33. Soguero C., Joo M., Chianese-Bullock K.A., Nguyen D.T., Tung K., Hahn Y.S. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J. Virol. 76:2002;9345-9354.
34. Sun J., Bodola F., Fan X., Irshad H., Soong L., Lemon S.M., Chan T.S. Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection. J. Virol. 75:2001;11992-11998.
35. Suzuki R., Matsuura Y., Suzuki T., Ando A., Chiba J., Harada S., Saito I., Miyamura T. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J. Gen. Virol. 76:(Pt. 1):1995;53-61.
36. Taya N., Torimoto Y., Shindo M., Hirai K., Hasebe C., Kohgo Y. Fas-mediated apooptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br. J. Haematol. 110:2000;89-97.
37. Toubi E., Kessel A., Goldstein L., Slobodin G., Sabo E., Shmuel Z., Zuckerman E. Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection Association with liver disease severity . J. Hepatol. 35:2001;774-780.
38. Watashi K., Hijikata M., Marusawa H., Doi T., Shimotohno K. Cytoplasmic localization is important for transcription factor nuclear factor-kappa B activation by hepatitis C virus core protein through its amino terminal region. Virology. 286:2001;391-402.
39. Yasui K., Wakita T., Tsukiyama-Kohara K., Funahashi S.I., Ichikawa M., Kajita T., Moradpour D., Wands J.R., Kohara M. The native form and maturation process of hepatitis C virus core protein. J. Virol. 72:1998;6048-6055.
40. Zhu N., Khoshnan A., Schneider R., Matsumoto M., Dennert G., Ware C., Lai M.M. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 72:1998;3691-3697.
41. Zhu N., Ware C., Lai M. Hepatitis C core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology. 283:2001;178-187.
42. Zignego A., Macchia D., Monti M., Thiers V., Mazzetti M., Foschi M., Maggi E., Romagnani S., Gentilini P., Brechot C. Infection of peripheral mononuclear blood cells by hepatitis C virus. J. Hepatol. 15:1992;382-386.